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Introduction: Bone marrow mesenchymal stem cells/multipotent stromal cells (MSCs) are recruited to sites of
injury and subsequently support regeneration through differentiation or paracrine activity. During periods of stress
such as wound site implant or differentiation, MSCs are subjected to a variety of stressors that might activate
pathways to improve cell survival and generate energy. In this study, we monitored MSC autophagy in response to
the process of differentiation.
Methods: MSC autophagosome structures were observed by using transmission electron microscopy and a
tandem green fluorescent protein-red fluorescent protein autophagic flux reporter to monitor the mammalian
microtubule-associated protein-1 light chain 3 (LC3) turnover in real time. MSCs were differentiated by using
standard osteogenic and adipogenic media, and autophagy was examined during short-term and long-term
differentiation via immunoblots for LC3I and II. Autophagy was modulated during differentiation by using
rapamycin and bafilomycin treatments to disrupt the autophagosome balance during the early stages of the
differentiation process, and differentiation was monitored in the long term by using Von Kossa and Oil Red O
staining as well as quantitative polymerase chain reaction analysis of typical differentiation markers.
Results: We found that undifferentiated MSCs showed an accumulation of a large number of undegraded
autophagic vacuoles, with little autophagic turnover. Stimulation of autophagy with rapamycin led to rapid
degradation of these autophagosomes and greatly increased rough endoplasmic reticulum size. Upon induction of
osteogenic differentiation, MSC expression of LC3II, a common autophagosome marker, was lost within 12 hours,
consistent with increased turnover. However, during adipogenic differentiation, drug treatment to alter the
autophagosome balance during early differentiation led to changes in differentiation efficiency, with inhibited
adipocyte formation following rapamycin treatment and accelerated fat accumulation following autophagosome
blockade by bafilomycin.
Conclusions: Our findings suggest that MSCs exist in a state of arrested autophagy with high autophagosome
accumulation and are poised to rapidly undergo autophagic degradation. This phenotype is highly sensitive, and a
balance of autophagy appears to be key in efficient MSC differentiation and function, as evidenced by our results
implicating autophagic flux in early osteogenesis and adipogenesis.* Correspondence: wellsa@upmc.edu
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Mesenchymal stem cells/multipotent stromal cells
(MSCs) have the ability to migrate into sites of injury,
self-renew, and differentiate as well as release trophic
and growth factors [1-4]. These activities combine to
bring about post-injury tissue regeneration, making them
prime candidates for use in regenerative medicine, in-
cluding repair of tissues such as bone and cartilage. For
purposes of therapy, MSCs are often implanted into
wound beds devoid of nutrients and oxygen and high in
reactive oxygen species and pro-inflammatory/pro-death
cytokines, which lead to a rapid loss of these cells [5-8].
However, endogenous MSCs contribute to wound heal-
ing, despite being subject to the harsh wound micro-
environment, suggesting that MSCs have an innate
mechanism of adapting to an environment low in nutri-
ents. In other situations, MSCs also face highly demand-
ing conditions during the process of expansion and
differentiation, where the cells are used to generate new
tissue; this has been studied in the contexts of myocar-
dial repair, epidermal skin healing, and many others
[9-12]. In either case, cellular mechanisms that can help
the cells prime themselves to efficiently overcome these
high metabolic demands would be advantageous to the
cell on an innate level and also as potential mechanisms
to improve clinical outcomes.
Macroautophagy, a conserved form of autophagy (and
called simply autophagy hereafter), is a catabolic process
of ‘self-eating’ or cannibalism wherein starving cells fuel
themselves by forming double membranous vacuoles
called ‘autophagosomes’ that sequester and degrade cyto-
plasmic material upon fusion with lysosomes. Tradition-
ally, autophagy has been considered a means of recycling
cellular components during times of nutrient starvation,
and indeed autophagosome formation is prevalent in cells
under nutrient deprivation and hypoxia [13,14]. Addition-
ally, autophagy plays a role in cellular differentiation such
as mitochondrial clearance during erythrocyte differenti-
ation or fat droplet deposition during adipocyte differenti-
ation [15]. Previous studies have found autophagosomes
to be present in MSCs [16-18] at a level higher than many
differentiated cells. This suggested that the autophago-
somes are altered during differentiation.
In this study, we queried whether autophagosomes play
a role during MSC differentiation and function and thus
could be potentially modulated to affect the differentiation
process. We used transmission electron microscopy
(TEM) and the autophagosome marker LC3II to deter-
mine that autophagosomes were more prevalent in the
MSCs than the differentiated cells, with the cells being
filled with autophagosomes. Using a tandem fluorescent
reporter to examine autophagic flux, we found that in
MSCs under normal conditions in vitro these autophago-
somes had not fused with lysosomes and therefore werenot being degraded or recycled. Additionally, a forced
release from this hold on autophagy led to rapid loss
of autophagosomes accompanied by expansion of the
rough endoplasmic reticulum (RER) indicative of cellular
reprogramming. We further studied differentiating MSCs,
showing activation of autophagy during early differenti-
ation and altered differentiation outcomes when autoph-
agy was modulated during the same time period. Our
results suggest a mechanism by which MSCs are arrested
in mid-autophagy while being maintained as multipotent
cells, allowing rapid generation of autophagosome degrad-
ation products when needed. This function could allow
the cells to adapt to challenging conditions in wound heal-
ing and ultimately may be a hallmark of a stem cell.
Materials and methods
Reagents
Dulbecco’s modified Eagle’s medium (DMEM) (10-014-
CV) was obtained from CellGro (Manassas, VA, USA).
RNase Minikit (74104) and Quantitect Reverse Transcrip-
tion Kit (205311) were obtained from Qiagen (Valencia,
CA, USA), and Brilliant SYBR Green Quantitative Poly-
merase Chain Reaction (qPCR) Master Mix (600548) was
from Agilent Technologies (Santa Clara, CA, USA). Bafilo-
mycin A1 from Streptomyces griseus (B1793) was obtained
from Sigma-Aldrich (St. Louis, MO, USA) and tamoxifen
citrate (54965-24-1) from ICN Biomed (Irvine, CA, USA).
For immunoblotting, rabbit polyclonal LC3 antibody
(NB100-2331) was obtained from Novus Biologicals
(Littleton, CO, USA) and goat anti-rabbit IgG secondary
antibody (A9169) was from Sigma-Aldrich. Housekeep-
ing gene anti-β-actin produced in rabbit (A2668) was
from Sigma-Aldrich. The protein ladder for all immu-
noblots was a Full Range Rainbow marker (RPN800E)
from GE Life Sciences (Pittsburgh, PA, USA).
Cell culture
Primary human bone marrow-derived multipotential stro-
mal cells (prhMSCs) were obtained from Darwin Prockop
at the National Institutes of Health-funded Stem Cell
Repository at Texas A&M University. These cells were
deemed exempt by the University of Pittsburgh Institu-
tional Review Board as they are provided without any pro-
tected health information or identifiers and do not require
the University of Pittsburgh to obtain informed consent.
These procedures comply with the Declaration of Helsinki.
Cells were maintained in alpha minimum essential medium
(α-MEM) without ribonucleotides or deoxyribonucleotides,
supplemented with 16.5% fetal bovine serum (FBS) (Atlanta
Biologicals, Lawrenceville, GA, USA), 100 units per mL
penicillin/streptomycin and 2 mM L-glutamine. Cells be-
tween P1 and P3 were used for experiments. A second hu-
man bone marrow-derived cell line, immortalized by using
human telomerase reverse transcriptase (ihMSCs), a kind
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was also used for studies. Proliferation media comprising
DMEM with 10% FBS (Gemini Bio-Products, West Sacra-
mento, CA, USA), containing 1 mM sodium pyruvate,
1 mM L-glutamine, 1 μM non-essential amino acids, and
100 units per mL penicillin-streptomycin, was used.
To account for changes in oxygen concentration, cells
were grown in either incubators at ambient air condi-
tions (21% oxygen) or Biospherix incubators (Biospherix,
Lacona, NY, USA) at 4% oxygen. At no point in the cul-
ture of cells at 4% oxygen were the cells exposed to am-
bient oxygen conditions, as the microscopes were also
contained in the Biospherix chamber.
For osteogenic differentiation media, proliferation media
was supplanted with 100 nM dexamethasone, 100 μM
β-glycerophosphate, and 50 μM L-ascorbic acid. Cells
were maintained in osteogenic differentiation media at ei-
ther 21% or 4% oxygen for up to 30 days. For adipogenic
differentiation, the hMSC adipogenic bulletkit (PT-3004)
from Lonza (Hopkinton, MA, USA) was used throughout
differentiation, and induction and maintenance media
were switched every three days.
Transmission electron microscopy
MSCs were grown to confluence in a six-well plate in
5.5 mM glucose and left untreated or treated with 5 μM
rapamycin or 5 nM bafilomycin for 1 hour or 4 hours.
After treatment, cells were fixed in 4% formaldehyde,
washed in phosphate-buffered saline (PBS), and proc-
essed as previously described [19]. Sections (70 nm)
were imaged on a Jeol JEM-1101 transmission electron
microscope (Jeol, Peabody, MA, USA), and autophago-
somes were captured at different magnifications as de-
scribed in the results.
Osteogenic differentiation
Immortalized human MSCs (ihMSCs) (up to passage 15)
were incubated in osteogenic DMEM for 72 hours (short
term) or 30 days (long term) at 21% or 4% oxygen. In
short-term studies, protein lysates were collected after 1,
3, 6, 12, 24, 48, and 72 hours of differentiation. Condi-
tions were included to modulate autophagy by using
5 μM rapamycin or 5 nM bafilomycin for the first
3 hours of differentiation to control short-term autoph-
agy outcomes. Protein lysates for all differentiations were
analyzed for changes in LC3 via immunoblot. LC3II
bands were normalized to β-actin control bands for each
time point and then standardized via sum of replicates
for each individual blot across three experiments [20].
Average normalized LC3II band density was calculated
with the resulting values for each experimental condi-
tion. For long-term studies, samples were collected after
0, 10, 20, and 30 days, with hydroxyapatite deposition
probed by Von Kossa stain. Briefly, samples were washedwith PBS without calcium or magnesium, fixed in 4%
paraformaldehyde, treated with 1% silver nitrate solu-
tion, and incubated under ultraviolet light for 10 minutes.
Wells were washed with sodium thiosulfate overnight
and imaged under transmitted light.
RNA was isolated from MSCs grown in osteogenic
media on days 0, 10, 20, and 30 by using an RNeasy kit
(Qiagen). After treatment with genomic DNA wipeout
buffer, 1 μg template RNA was reverse-transcribed into
cDNA by using a Quantitect cDNA kit (Qiagen). qPCR
was performed by using 1 μL cDNA for all samples with
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as
control, 12.5 μL of Brilliant SYBYR green master mix
(Agilent Technologies), and 3.75 μL forward and reverse
primers. Primers for Runx2 and Osteocalcin, markers
for early and late osteogenesis, were used to probe for
osteogenesis. Forward and reverse primer sequences
were the following:
GAPDH forward primer: 5′-GAGTCAACGGATTTGG
TCGT-3′
GAPDH reverse primer: 5′-TTCATTTTGGAGGGATC
TCG-3′
Runx2 forward primer 5′-CCTCGGAGAGGTACCAG
ATG-3′
Runx2 reverse primer 5′-TTCCCGAGGTCCATCTAC
TG-3′
Osteocalcin forward primer 5′-GTTTATTTGGGAGC
AGCTGGGATG-3′
Osteocalcin reverse primer 5′-GTTTATTTGGGAGCA
GCTGGGATG-3′.
Adipogenic differentiation
Up to passage 10, ihMSCs were grown to confluence in
standard DMEM (see above) at 21% oxygen. Samples
were then treated with adipogenic differentiation media
(Lonza, see above) and assayed for fat droplet formation
after 10, 20, and 30 days. To monitor the effects of
modulating early autophagy on the long-term differenti-
ation process, separate groups were treated with 5 μM
rapamycin or 5 nM bafilomycin for the first 3 hours of
differentiation, after which normal adipogenic media was
used for the rest of the 30-day study.
At each time point, fat droplet accumulation was
assayed by using Oil Red O staining. For the Oil Red
O reagent, stock solutions were prepared by using
3 mg/mL Oil Red O (O-0625) (Sigma-Aldrich) in isopro-
panol. Working solutions consisted of 3:2 Oil Red O
stock in deionized water. For staining, cells were fixed in
4% paraformaldehyde, washed, and treated with 60%
ethanol for 5 minutes. Oil Red O stain was added for
5 minutes, and samples were imaged for fat droplet for-
mation, with droplets appearing red under transmitted
light. Adipocyte differentiation was interpreted as the
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lated by using ImageJ by converting all 20× images to 8-
bit format and reducing threshold to highlight the red
adipocytes in culture, using the same thresholding for all
analyzed images. Particle analysis in ImageJ was set to
detect any droplets with a radius greater than 75 pixels
to exclude debris and miniscule droplets. Percentage
areas of each image occupied by adipocytes were aver-
aged by using eight fields across two experiments, and
percentage area measurements were compared at days
20 and 30 of differentiation when significant fat accumu-
lation was seen.
Assessment of autophagosome turnover
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was
used to transfect MSCs with a monomeric red fluorescent
protein-green fluorescent protein (mRFP-GFP) tandem
fluorescently tagged LC3 plasmid (tfLC3), a kind gift from
Tamotsu Yoshimori’s lab, Osaka University, Japan [21].
The plasmid is designed in a manner that both RFP and
GFP are expressed in autophagosomes on LC3 until fusion
with the lysosome. Once in the acidic compartments of
the lysosome, GFP-LC3 fails to fluoresce while RFP-LC3
continues to generate a fluorescent signal. For transfec-
tion, 1 μg of plasmid was diluted in Optimem and mixed
in a 1:1 ratio with Lipofectamine 2000 diluted 1:25 in
Optimem. This mixture was incubated for 20 minutes
at room temperature and added to MSCs grown to 70%
confluence in 5.5 mM or 25 mM glucose media without
FBS. MSCs were allowed to sit in this mix for 6 hours,
after which cells were placed in complete media. Media
without FBS was used instead of Optimem because of
MSC death in the presence of Optimem alone.
Cells were left untreated, to probe for basal autophago-
some recycling, or treated with 5 μM rapamycin (LC
Laboratories, Woburn, MA, USA) or 5 nM bafilomycin
(B1793-2UG) (Sigma-Aldrich) for 15 minutes or 1 hour
and imaged for RFP and GFP fluorescence. Whereas yel-
low (merge of GFP and RFP) puncta indicate autophago-
somes prior to fusion with lysosomes, red puncta indicate
autophagosomes post fusion with lysosomes [21].
Statistical analysis
In analyses for osteogenic marker expression and fat
droplet percentage area, all treatments were compared
by using a Student’s t test, and a P value of less than
0.05 was considered statistically significant.
Results
Mesenchymal stem cells contain a large number of
mid-stage autophagosomes
We have earlier reported that MSCs generate reactive
oxygen species despite being largely glycolytic [5,22,23].
As such, we examined the mitochondrial content ofihMSCs by using TEM. Interestingly, we found a large
number of mitochondria, but unexpectedly these were at
least partially encapsulated in autophagosomes (Figure 1).
The autophagosomes do not appear to have fused with
lysosomes, and the ratio of early autophagosomes to
late/‘empty’ ones is abnormally high (Figure 1) and thus
they seem to have accumulated in a partial arrest prior
to lysosomal degradation. In contrast, 1-hour treatment
with rapamycin, a drug that inhibits mammalian target
of rapamycin (mTOR) signaling and stimulates autophagy
[24], led to rapid clearance of previous autophagosome
clusters that also coincided with an increase in RER size
(Figure 1). After 4 hours of rapamycin treatment, the
remaining autophagosomes seem to have cleared com-
pletely, and the RER size returned to a more normal state
(data not shown). Early stages of new autophagosome for-
mation appear to emerge after 4 hours of rapamycin
stimulation, consistent with a new cycle of autophagosome
generation. This pattern of autophagosome utilization was
not present in untreated MSCs.
Analysis of prhMSCs shows a similar phenotype though
not as striking as what is seen with the telomerase-
immortalized cells (Figure 1). Notably, the smaller cells in
prhMSC cultures were the ones that showed the higher
autophagosome concentrations, in contrast with a more
constant high concentration in the immortalized cells.
Treatment with rapamycin for 1 hour led to autophago-
some degradation as seen in the ihMSCs; RER enlargement
was also noted though again to a lesser extent than in the
immortalized MSCs (Figure 1). Nevertheless, the autopha-
gosome accumulation and changes upon induction were
qualitatively similar in both the immortalized and primary
human MSCs.
Autophagy is highly active during the early stages of
mesenchymal stem cell differentiation
Recent evidence has suggested that autophagy occurs in
MSCs and more importantly plays a role in a critical early
period (approximately 3 hours) during the differentiation
process [18]. We first looked at how MSCs responded to
the first few days of differentiation with respect to changes
in LC3, a common marker for autophagosome degradation.
Immortalized MSCs were grown to confluence and exposed
to standard osteogenic differentiation media for 72 hours,
and lysates were collected for immunoblot analysis of LC3
at various time points (Figure 2A). To examine changes in
LC3 compared with standard drug treatments to modulate
autophagy, we also included treatments of rapamycin and
bafilomycin (a drug that inhibits autophagy) in separate
groups to control MSC autophagy during the aforemen-
tioned critical window, followed by replacement of the
media with the normal differentiation media (Figure 2A).
About 15 autophagy-related proteins act in a hierarchical
manner to bring about initiation, nucleation, elongation,
Figure 1 Mesenchymal stem cells (MSCs) show a high number of autophagosomes. Immortalized human MSCs grown at standard culture
conditions (1 g/L glucose, 10% fetal bovine serum, or FBS) or following treatment with 5 μM rapamycin for 1 hour were subjected to transmission
electron microscopy analysis at 15,000× magnification (top). A 150,000× image of a late-stage autolysosome is included with the control treatment
(top left inset), as is a 40,000× magnification of residual autophagosome structures in the rapamycin treatment (top right inset). Primary human MSCs
were analyzed for autophagosome formation at standard conditions (1 g/L glucose, 16.5% FBS) at 40,000× (bottom left) and following 5 μM rapamycin
treatment for 1 hour at 10,000× (bottom right). ihMSC, immortalized human mesenchymal stem cell; prhMSC, primary human mesenchymal stem cell.
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microtubule-associated protein-1 light chain 3 (LC3) is part
of the elongation-closure machinery of autophagosomes. It
is present either in a form unconjugated to lipids called
LC3I that is widely distributed in the cytoplasm or in a
form conjugated to the lipid phosphotidylethanolamine and
bound to both membranes of the mature autophagosome
called LC3II [26]. LC3II is a commonly used marker for
autophagosomes since it migrates to a lower position dur-
ing electrophoresis [27]. LC3 immunoblotting is generally
assessed by the relative changes in LC3II (lower band) over
time, signifying the degradation of autophagosomes by the
lysosome, which decreases LC3II that has been localized to
the autophagosome membrane. Osteogenic differentiation
results in Figure 2A and B show a marked and rapid reduc-
tion LC3II, decreasing from a high initial level across the
course of treatment, with a notable reduction in LC3II just
after 3 hours of differentiation stimulus (with relativelyconstant cytosolic LC3I, as seen in the blots in Figure 2A
and quantitated by densitometry across repeat experiments
in Figure 2B). There was also an apparent recovery follow-
ing the initial activation of autophagic flux, as cytosolic
LC3I levels increased at 24 hours and a subsequent partial
recovery of LC3II levels was observed (Figure 2B).
This control differentiation showed a trend similar to
the rapamycin-treated cells, which showed a similar rapid
clearance of LC3II and subsequent re-accumulation of
LC3 after 24 hours of differentiation. This effect was
inhibited by bafilomycin treatment, which limited LC3II
turnover and generally inhibited LC3II degradation, most
notably at the 6-hour mark when the average LC3II dens-
ity was greatly increased in the bafilomycin treatment
compared with the control and rapamycin treatments.
Bafilomycin treatment also led to a distinctly higher aver-
age LC3II level later in the time course, suggesting a po-
tentially higher available number of autophagosomes in
Figure 2 High autophagosome concentration is consumed during early immortalized human mesenchymal stem cell differentiation.
(A) Immortalized human mesenchymal stem cells were differentiated under osteogenic conditions (see Materials and methods) and assayed for
changes in LC3I and LC3II during a 72-hour window. Cells were differentiated under standard conditions (top) or with addition of 5 μM rapamycin
(middle) or 5 nM bafilomycin (bottom) for the first 3 hours of differentiation to modulate autophagy. Immunoblots were performed for LC3
at the indicated time points to assess autophagosome degradation via relative changes in LC3II (lower band; 17 kDa). Studies were repeated
three times with similar trends seen consistently. (B) Average standardized densities normalized by the sum of replicates were quantified via
densitometry to measure autophagosome accumulation (LC3II bands) across three separate differentiations. Average values as standardized to
β-actin are reported here. LC3, light chain 3.
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treatment at the onset of differentiation. These results sug-
gest that standard osteogenic differentiation cues mobilize
the accumulated autophagosomes in MSCs within 3 to
6 hours, which is followed by a ‘re-loading’ of autophago-
somes following the utilization of the initial flux. Further-
more, the ability of this differentiation-stimulated flux to
be inhibited by drug treatment suggests that this pheno-
type may be able to be exploited during differentiation, de-
pending on clinical goals, and ultimately supports the
hypothesis of a critical role for autophagosome accumula-
tion and utilization in MSC differentiation.Given the long-term nature of MSC differentiation
and the need for energy generation during potential
stressors such as hypoxic conditions, we also assayed
how LC3 levels were affected during differentiation of
MSCs into osteoblasts over 30 days in standard culture
(21%) or more rapidly under the more physiologically
relevant (4%) oxygen concentrations. Differentiation pro-
ceeded as expected, and hydroxyapatite deposition was
seen by using Von Kossa stain after 10 days at 4% oxy-
gen and after 20 days at 21% oxygen (Figure 3D). qPCR
analysis of early and late osteogenesis markers (Runx2
and Osteocalcin levels) confirmed this, and more rapid
Figure 3 (See legend on next page.)
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Figure 3 Autophagy mobilized during differentiation of immortalized human mesenchymal stem cells (ihMSCs). Cultured ihMSCs were
stimulated to undergo osteogenesis to form osteoblasts for 30 days at 21% and 4% oxygen. LC3I and LC3II levels were assessed via immunoblot
every 10 days and normalized to β-actin to derive average LC3II band densities (A). Levels of Runx2 (B) and Osteocalcin (C), markers of early and
late osteogenesis, respectively, were assayed via quantitative polymerase chain reaction (#P <0.05, *P <0.01). A Von Kossa stain was employed
every 10 days to visualize bone spicule deposition at both oxygen concentrations (D). The representative of experiments repeated at least three
times is shown, and statistical significance is noted for difference from day 0 and between the two different ambient oxygen concentrations.
Immunoblot normalized integrated densities were calculated and averaged by using a ratio of LC3II to beta-actin via sum of replicates for each
blot. LC3, light chain 3.
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(Figure 3B and C). In terms of the autophagy phenotype,
autophagosome marker LC3II was generally decreased
by differentiation, relative LC3II levels fell by 10 days at
4% O2 and 20 days in 21% O2, and the different rates coin-
cided with the bone deposition seen in culture (Figure 3A).
LC3 expression on the whole also diminished during
differentiation, as seen particularly in the more robust
differentiation at 4% oxygen that resulted in reduced band
intensity for both LC3I and LC3II, suggesting turnover of
both LC3 pools with resultant decreases in autophagic
potential as the cells form osteoblasts.
Differences in LC3 reduction seem to be directly
related to oxygen concentration, which clearly has an
effect on the rate of bone deposition, both early- and
late-stage. Differentiation was much more rapid at 4%
oxygen, which coincided with the more rapid LC3II re-
duction. This result suggests that MSCs may release
from their unfused autophagosome state during times of
high energy demand, such as during differentiation.
Ultimately, the ‘pre-autophagy’ phenotype is seen only in
functional and undifferentiated MSCs and may be a hall-
mark of such a cell.
Modulation of differentiation outcomes through
autophagy regulation
Data in Figures 2 and 3 suggest a key role for autophagy
in MSC differentiation, particularly during the early crit-
ical period as the cells initiate the differentiation process.
Earlier work demonstrated limited adipose tissue in mice
lacking the critical effector Atg7 (autophagy-related gene
7) in adipocytes [28,29]. We hypothesized that the nature
of autophagy’s apparent utility in differentiation would
lead to altered differentiation outcomes if autophagy was
modulated in the key early window of the process in gen-
eral and thus examined a second differentiation pathway
of adipogenesis. To test this, we differentiated immortal-
ized MSCs into adipocytes by using commercial adipo-
genic media over the course of 30 days, in the face of
5 μM rapamycin or 5 nM bafilomycin treatments during
the first 3 hours of differentiation (as in Figure 2) to alter
the autophagic balance at the onset of differentiation.
Surprisingly, fat droplet accumulation via Oil Red O
staining showed that bafilomycin treatment to block theautophagosome utilization early in differentiation led to
a more robust differentiation/fat droplet accumulation
over 30 days in the MSCs (Figure 4A). Quantification of
fat droplets on day 20 showed little difference among
treatments, and this was presumably due to the low
amount of mature adipogenesis in general to this time
point (Figure 4B). However, at day 30 when substantial
fat accumulation was seen in culture, adipocyte percent-
age area quantification showed a significant increase in
adipocyte accumulation in the bafilomycin-treated con-
dition. This stands in contrast to the rapamycin treat-
ment, which showed a slight decrement (that was not
statistically significant) compared with the control differ-
entiation. Thus, our results show that briefly delaying
the induction of autophagy in adipogenic differentiation
improves long-term differentiation outcomes and suggests
a potential key role for autophagy and the balance of
autophagosome accumulation/cycling in MSCs early in
commitment to lineage. Additionally, we show here that
autophagy plays a role across multiple differentiation path-
ways, suggesting a key role in general MSC physiology and
potential clinical utility in many contexts.
Autophagic turnover is halted in mesenchymal stem cells
MSCs analyzed by TEM showed a high concentration of
autophagosome structures (Figure 1). However, single
time points seen in TEM images did not reveal whether
these led to degradation of the contents. The absence of
late-stage autophagosomes hinted at an arrest in cycling,
but nothing definitive could be garnered by these snap-
shots. Given the apparent dynamic role of autophagy in
differentiation and the rapid change in phenotype seen
in these cells, we examined the baseline status of any au-
tophagic turnover in normal MSCs. To examine matur-
ation and flux of autophagosomes over time, we used a
tandem GFP-RFP LC3 plasmid to monitor the local pH
environment of LC3II puncta. This plasmid tags LC3
in the cell with both GFP and RFP, and thus when LC3II
is present in non-acidified autophagic structures, the
green and red co-localize to show a yellow tag. However,
the acidic environment necessary for lysosomal degrad-
ation of the autophagosome quenches the GFP signal,
and thus any autophagosomes that have fused with
active lysosomes will show only the RFP signal. This
Figure 4 (See legend on next page.)
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Figure 4 Early arrested autophagy can be modulated to alter immortalized human mesenchymal stem cell adipogenesis outcomes. (A)
Immortalized human mesenchymal stem cells differentiated under adipogenic conditions were left untreated or treated with 5 μM rapamycin or
5 nM bafilomycin for the first 3 hours of differentiation. Differentiation outcomes were monitored via changes in fat droplet accumulation by
using an Oil Red O stain. (B) Fat droplet percentage area in individual images was quantified by using thresholded images to monitor adipocyte
formation. Analysis was performed by using representative images from eight-image fields across two studies (#P <0.05).
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hagosome turnover in real time [21].
Immortalized MSCs showed very little loss of GFP
signal over time, indicating a lack of turnover of LC3II
and suggesting arrested autophagic degradation in the
cells (Figure 5). The yellow signal from GFP/RFP co-
localization was quickly lost after 15 minutes of treat-
ment with rapamycin to induce autophagy, and almost
all GFP signal was quenched after 1 hour in rapamycin.
Furthermore, treatment with bafilomycin to halt autoph-
agy showed no appreciable effect on fluorescent signal
in the ihMSCs. Given that bafilomycin halts autophagy
by preventing lysosomal fusion and degradation, this
phenotype would be expected in cells that already are
arrested in maturation prior to forming acidified autoly-
sosomes. Ultimately, little turnover of GFP signal (and
thus autophagosome recycling) is seen unless stimulated
with rapamycin. This suggests that, although MSCs do
have a significant level of basal autophagosome forma-
tion, a great deal of these autophagosomes appear to be
arrested in the middle of the autophagic process prior to
lysosomal degradation. The cells are poised to be rapidly
released from this state when cues signaling a need for
autophagic degradation products are received (as occurs
with mTOR inhibition).
Discussion
Macroautophagy exists to quickly generate energy sub-
strates during cellular stress due to nutrient deprivation,
to remove unnecessary organelles during differentiation
state changes, and/or to generate precursors for macro-
molecular syntheses. Understanding of its role and
even its existence, in stem cell biology remains nascent,
particularly in MSCs. Previous studies of autophagy in
stem cells in general have shown a slightly nebulous but
suggestive role of the autophagic processes in normal
cell function and differentiation. Embryonic stem cells,
for example, have been claimed to have constitutive
levels of autophagy on the basis of an upregulation of
autophagy proteins early during differentiation [30].
Additionally, reprogramming of somatic cells to induced
pluripotent stem cells has been shown to involve the
process of autophagy and its signaling pathways [31,32].
Limited study of MSC autophagy has shown a significant
constitutive level of autophagy-associated proteins to be
upregulated in these cell, with potential early activation
and, later, loss of the phenotype during differentiation[17,18]. Additionally, production of the autophagic ma-
chinery has been shown to have a protective role during
MSC starvation [16]. These reports all delineate a pos-
sible role of the process in generating energy or precur-
sors for stem cells during times of stressed metabolic
demand, such as differentiation, reprogramming, or star-
vation. Herein, we show that in an undifferentiated state,
MSCs present an arrest in autophagy prior to autopha-
gosome degradation by the lysosome. This effect is seen
in both immortalized and primary cell lines, though to a
less dramatic extent in the primary cells. Most import-
antly, the autophagic phenotype is lost during cellular
differentiation.
Given the high concentration of autophagosomes in
MSCs, the key role in differentiation, and the general lack
of autophagic turnover at a basal state, we propose a
model wherein MSCs exist in a state of ‘arrested’ autoph-
agy, where an unusually high concentration of autophago-
somes sit in the cells prior to lysosomal degradation
(Figure 6). This arrested phenotype could be used to rap-
idly generate amino acid building blocks when necessary
via autophagy, as indicated by RER enlargement following
rapamycin stimulation in Figure 1. Although this RER en-
largement is less pronounced in the primary cells, the
mechanism is still present and could be less dramatic be-
cause of fewer autophagosomes present at baseline in pri-
mary cells. For example, cells undergoing differentiation
may take advantage of this phenotype to rapidly generate
precursors during the demanding differentiation process
in a wound arena with limited perfusion or might take
advantage of these arrested energy stores for situations
where the cells are challenged to survive, such as in clin-
ical cell therapy settings, including chronic skin wounds
or myocardial defects.
A halted autophagic process may in fact be a hallmark
of undifferentiated MSCs. Moreover, this novel autopha-
gic characteristic of MSCs may play a key role in their
physiology during wound healing. Cells in a wound
environment are subject to a variety of stressors and
challenges to their survival, making mechanisms like au-
tophagy key for allowing stem cells to exist long enough
to proliferate and differentiate effectively into the target
cell type. In arresting autophagy before lysosomal deg-
radation, MSCs have a method to rapidly release sub-
strates for lysosomal degradation, generating energy and
anabolic resources for the cell, as seen in the accom-
panying RER expansion. Additionally, although glycolysis
Figure 5 Immortalized human mesenchymal stem cells show little autophagosome turnover unless stimulated. Immortalized human
mesenchymal stem cells grown under normal culture conditions were tagged with a tandem green fluorescent protein-red fluorescent protein
(GFP-RFP) light chain 3 (LC3) via viral transfection (see Materials and methods). ihMSCs were then stimulated with bafilomycin to halt autophagy
for 1 hour or with rapamycin to induce autophagy for 15 minutes and 1 hour. The representative of experiments repeated at least three times
is shown.
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resynthesizing mitochondria via this mechanism, the
MSCs present the machinery for rapid macromolecule
synthesis in nutrient-rich environments while providing
materials for autophagic degradation and recycling of
macromolecular building blocks. This mechanism may
play a key role in how MSCs function in a wound bed
and could also be manipulated to promote cell survival
further in cell transplant scenarios, in which MSCs aresubject to stressors that might activate an autophagic re-
sponse in the cell.
Given the role of autophagy activation early in MSC
differentiation that we have discussed here, our results
showing the altered differentiation outcomes present an
interesting possibility for affecting MSC differentiation
across a variety of scenarios. Here, we showed inhibiting
the autophagic flux activated by MSCs at the initiation
of differentiation with a modest bafilomycin treatment
Figure 6 Schematic for arrest and utilization of autophagy in normal mesenchymal stem cell (MSC) function. As evidenced by
transmission electron microscopy images and green fluorescent protein-red fluorescent protein tracking of light chain 3 in this study, undifferentiated
MSCs appear to exist at a state of high basal autophagy, with many autophagosomes in a state of arrest in the cytosol (left). Artificial activation of
autophagosome degradation with rapamycin (right) leads to a rapid clearance of existing autophagosomes in the cell, with subsequent rough
endoplasmic reticulum (RER) enlargement, suggesting a potential advantage for MSCs to mobilize autophagy during times of high energy
demand. Thus, during a time such as differentiation or nutrient starvation (bottom), a similar phenotype is observed in the cells whereby
arrested autophagosomes in the cell are mobilized and degraded, allowing the MSCs to proceed in the differentiation process or potentially
resist negative effects of stressors. mTOR, mammalian target of rapamycin.
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ferentiation over the course of 30 days. Notably, this re-
sult stands in apparent contrast to the mouse model that
is deleted for Atg7, a key regulator of autophagy, specif-
ically in adipocytes [29]. Studies using this model
showed that the constitutive impairment of autophagy in
the knockout mice significantly reduced adipogenesis,
suggesting a key role for autophagy in the adipogenic
process. At a high level, this appears to be discrepant
with the results herein. However, the autophagy block-
ades in these two models are substantially different.
Impaired autophagy in the Atg7 knockout is on a per-
manent basis, disrupting autophagy and autophagosome
cycling in fat beyond early stages of a differentiation
process. Our results from a transient blockade of au-
tophagy just during the earliest stages of differentiation
support an activation of autophagy during early differen-
tiation but appear to differ from the effects of the long-
term autophagy blockade. For a transient inhibition,
during a key early period in the initiation of adipogenesis
where an innate accumulation of autophagosomes exists,
preventing the cells from immediately cycling autopha-
gosomes as they normally do may in fact allow the cellsto more effectively use the autophagosome accumulation
we have shown here. In total, these findings suggest that
MSCs may ultimately benefit from delaying the onset of
autophagic cycling to preserve the autophagosome balance
beyond the normal time to autophagosome degradation.
By altering this autophagic phenotype early in the
process and then allowing normal autophagy to occur,
the cells are seemingly able to undergo a more efficient
differentiation. Furthermore, we propose that holding
the cells from cycling autophagosomes too early in the
process may be beneficial to particular differentiation
pathways and that placing cells in a pro-autophagy en-
vironment such as nutrient stress or hypoxia might hin-
der adipogenic differentiation if the MSCs are unable to
maintain the autophagosome balance and activate cyc-
ling at the appropriate time. Additionally, this suggests
that drugs to modulate autophagy might be tangentially
used to affect desired differentiation outcomes in culture
settings or also in vivo if a differentiation is desired in a
clinical setting. Further study of this phenotype across
various differentiation pathways is warranted, particu-
larly establishing the specific pathway of activation that
links differentiation and autophagy activation and also
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tion that is the underlying key to this unique activity
of MSCs. Although the phenotype as it relates to LC3
levels was qualitatively similar across both pathways
studied here, more detailed analysis of specific utilization
of autophagosomes and the utility of modulating au-
tophagy is warranted in MSCs.
Conclusions
Often hMSCs are placed into scenarios where metabolic
demand is high and the environment demands increased
energy output to function, such as cell stress in a cell
transplant site or during differentiation. Autophagy is a
well-known process by which MSCs might mobilize au-
tophagic degradation to induce recycling of components
for protein production and other key energy factors.
Herein, we show that autophagosome concentrations are
extremely high in MSCs at a basal state, showing an
arrested phenotype prior to lysosomal degradation. This
arrest is easily mobilized by stimulating conditions, lead-
ing to increased RER size and normal autophagy after
mobilization. Furthermore, autophagy is mobilized very
early in the process of differentiation in MSCs, confirm-
ing a key role for autophagy in the differentiation
process. As such, altering the state of autophagy during
the early stages of differentiation changes the long-term
differentiation efficiency of the MSCs. Our results here
further support a key role for autophagy in several differ-
entiation pathways in MSCs and also present a potential
utility for autophagy modulation in optimizing MSC dif-
ferentiation or utility in cell therapy to improve thera-
peutic benefit.
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